What are the treatment options for patients with duodenal cancer who have progressed on FOLFIRINOX?

What is the quality of evidence behind these options?

Answer from: Medical Oncologist at Academic Institution

The quality of evidence for almost all treatments in small bowel adenocarcinomas is poor to some extent. First, I would look at the NGS data I am sure you have or can obtain easily for a molecular treatment if applicable (TMB > 10 = pembrolizumab, MSI-H = checkpoint inhibitor, NTRK = e.g. entrect...

Comments

Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Just to add that S1922 is testing whether taxane h...

Please select the option that best describes you:

What are the treatment options for patients with duodenal cancer who have progressed on FOLFIRINOX?

Related Questions